Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-17

Clinical Trial Update: Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy [NA]

View source ↗

Summary

A completed clinical trial evaluated Coenzyme Q10 as an adjunctive therapy for drug-resistant epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Epilepsy, Drugs Resistance | NA | Status: COMPLETED